Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04579406
What this trial is testing

Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients

Who this might be right for
Type 2 DiabetesNeuropathy
Second Hospital of Shanxi Medical University 200
Not applicableStudy completedNCT05370612
What this trial is testing

AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy

Who this might be right for
Type2DiabetesPregnancy in Diabetic
University of Wisconsin, Madison 16
Not applicableStudy completedNCT03722199
What this trial is testing

Effects of Flavanoids in Essential Hypertension, Type 2 Diabetes and Healthy Persons

Who this might be right for
Vascular Complications, Diabetic
University Ghent 43
Not applicableUnknownNCT02903199
What this trial is testing

Whey Protein Effect on Glycaemic and Appetite Responses in T2D

Who this might be right for
Type II Diabetes MellitusGlucose Metabolism DisordersMetabolic Diseases
Northumbria University 11
Not applicableStudy completedNCT07165119
What this trial is testing

The Effect of the Interdisciplinary Care Approach on General Health Parameters in Older Adults With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hacettepe University 48
Early research (Phase 1)Study completedNCT01924767
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 48
Post-approval studies (Phase 4)UnknownNCT03631134
What this trial is testing

Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin

Who this might be right for
Type2 Diabetes
Nanjing First Hospital, Nanjing Medical University 100
Not applicableStudy completedNCT01580904
What this trial is testing

Impact of Pharmaceutical Care in Diabetics Patients

Who this might be right for
Diabetes Mellitus Type 2
Universidade Estadual da Paraiba 100
Not applicableStudy completedNCT02625649
What this trial is testing

Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes MellitusObesityDiabetic Retinopathy+1 more
University of Aarhus 148
Not applicableStudy completedNCT02135549
What this trial is testing

Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Boston Therapeutics 24
Early research (Phase 1)Study completedNCT01441232
What this trial is testing

Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 18
Not applicableStudy completedNCT00931034
What this trial is testing

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women

Who this might be right for
Type 2 Diabetes Mellitus
Mondelēz International, Inc. 120
Not applicableStudy completedNCT01938521
What this trial is testing

Effects of Red Grape Cells (RGC) Powder in Type 2 Diabetics

Who this might be right for
Type 2 Diabetes
Tel Aviv University 40
Post-approval studies (Phase 4)Study completedNCT01165684
What this trial is testing

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 401
Post-approval studies (Phase 4)Study completedNCT01028287
What this trial is testing

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

Who this might be right for
Diabetic NephropathyNephrotic Syndrome
Southeast Renal Research Institute 15
Not applicableLooking for participantsNCT06586203
What this trial is testing

Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular DiseasesDiabetic Nephropathy Type 2
Optithera 2,714
Not applicableUnknownNCT00655603
What this trial is testing

Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 20
Post-approval studies (Phase 4)Study completedNCT00290394
What this trial is testing

Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Baskent University 25
Not applicableStudy completedNCT00937703
What this trial is testing

Multicentric Evaluation of Two Telematics Systems in Type 2 Diabetic Patients in Failure of Oral Treatment and Having to Start Treatment by Basal Insulin

Who this might be right for
TYPE 2 DIABETES
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète 180
Not applicableStudy completedNCT02316522
What this trial is testing

Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population

Who this might be right for
Type 2 Diabetes
Weill Medical College of Cornell University 158
Next Page